To characterize the immunologic and inflammatory state and dynamics of patients with COVID-19 using routine clinical laboratory data and develop methods to provide risk stratification and to generate mechanistic hypotheses regarding disease progression.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. John HigginsResearch Location
United States of AmericaLead Research Institution
Massachusetts General HospitalResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified